Researchers
- TANIZAKI Junko
- Lecturer
| Faculty | Department of Medicine |
|---|---|
| Researchmap | https://researchmap.jp/tanizaki_j |
Education and Career
Education
- - 2007/03 , Kindai University, Faculty of Medicine,
- 2009/04 - 2012/03 , Kindai University, 大学院医学研究科 医学腫瘍生態制御学,
Academic & Professional Experience
- Apr. 2021 - Today , 近畿大学医学部内科学教室 腫瘍内科部門 医学部講師
- Apr. 2018 - Mar. 2021 , 市立岸和田市民病院 腫瘍内科 医長
- Apr. 2015 - Mar. 2018 , 近畿大学医学部内科学腫瘍内科部門 助教
- Aug. 2012 - Mar. 2015 , Dana－Farber Cancer Institute Post-doctoral Fellow
- Apr. 2009 - Jul. 2012 , 近畿大学医学部 内科学腫瘍内科部門 助教
- Apr. 2007 - Apr. 2009 , 近畿大学医学部附属病院 臨床研修医
Research Activities
Research Areas
- Life sciences, Tumor diagnostics and therapeutics
Published Papers
-
Phase Ia/Ib trial of the safety and efficacy of mobocertinib in combination with T-DM1 for patients with HER2-mutant solid tumors (WJOG16022M).
Hiroaki Kanemura; Junko Tanizaki; Koji Matsumoto; Toshiki Masuishi; Taichi Isobe; Hirotsugu Kenmotsu; Yu Sunakawa; Toshio Shimizu; Yasutaka Chiba; Nobuyuki Yamamoto; Kazuhiko Nakagawa; Hidetoshi Hayashi
European journal of cancer (Oxford, England : 1990) 238 , 116684-116684, 19, Mar. 2026 -
Recovery from fulminant immune-related myocarditis induced by ipilimumab plus nivolumab in malignant pleural mesothelioma: a case report.
Yuki Konya; Junko Tanizaki; Kyohei Onishi; Hiroki Matsuzoe; Hiroaki Kanemura; Takayuki Takahama; Kaoru Tanaka; Gaku Nakazawa; Hidetoshi Hayashi
BMC pulmonary medicine 10, Mar. 2026 -
Development of Second Primary Malignancies in Long-term Survivors of Unresectable Esophageal Cancer.
Ryotaro Watanabe; Seiichiro Mitani; Masaki Okura; Chiaki Inagaki; Junko Tanizaki; Kaoru Tanaka; Tsutomu Iwasa; Kimio Yonesaka; Hidetoshi Hayashi
Cancer diagnosis & prognosis 6 (2) , 359-367, 2026
Conference Activities & Talks
- Nivolumab for cancer of unknown primary (CUP): clinical efficacy and biomarker analysis from NivoCUP2 expanded access program (WJOG14620M) , J. Tanizaki; K. Yonemori; Y. Takiguchi; K. Akiyoshi; K. Komine; Y. Onozawa; M. Sato; K. Hirata; T.Onoe; T. Ishiguro; A. Ito; Y. Chiba; H. Watanabe; Y. Togashi; K. Sakai; K. Nishio; K.Nakagawa; H. Hayashi , 2024 ESMO , 15, Sep. 2024
- Clinical features of long-term response to immune checkpoint inhibitors in patients with advanced or recurrent NSCLC , Waka Dohi; Hiroaki Kanemura; Junko Tanizaki; Shinichiro Suzuki; Takayuki Takahama; Kaoru Tanaka; Tsutomu Iwasa; Kimio Yonesaka; Hidetoshi Hayashi , 2024 世界肺癌学会 , 8, Sep. 2024
- Phase Ia/Ib trial on the safety and efficacy of mobocertinib in combination with T-DM1 for patients with HER2-mutant solid tumors (WJOG16022M). , Hiroaki Kanemura; Junko Tanizaki; Koji Matsumoto; Toshiki Masuishi; Taichi Isobe; Hiroaki Kodama; Toshio Shimizu; Yu Sunakawa; Yasutaka Chiba; Nobuyuki Yamamoto; Kazuhiko Nakagawa; Hidetoshi Hayashi , 2024 ASCO , 1, Jun. 2024
MISC
- Chromosomal instability leads to EGFR-TKI refractoriness via cGAS-STING activation in EGFR-mutated non-small cell lung cancer , Kimio Yonesaka; Takashi Kurosaki; Junko Tanizaki; Hisato Kawakami; Kaoru Tanaka; Osamu Maenishi; Shiki Takamura; Kazuko Sakai; Yasutaka Chiba; Takeshi Teramura; Hiroki Goto; Eri Otsuka; Hiroaki Okida; Masanori Funabashi; Yuuri Hashimoto; Kenji Hirotani; Yasuki Kamai; Takashi Kagari; Kazuto Nishio; Kazuhiro Kakimi; Hidetoshi Hayashi , CANCER RESEARCH , 85 , 8 , 15, Apr. 2025
- ペムブロリズマブによるサイトカイン放出症候群に対して血漿交換が奏効した1例 , 宮田将行; 谷崎潤子; 大倉將生; 土肥和佳; 金村宙昌; 高濱隆幸; 田中薫; 米阪仁雄; 林秀敏 , 肺癌(Web) , 65 , 6 , 2025
- 小細胞肺癌十二指腸転移疑い病変が治療経過により十二指腸癌と判明した1例 , 紺屋友希; 宮田将行; 太田龍一; 谷崎潤子; 大倉將生; 土肥和佳; 金村宙昌; 高濱隆幸; 田中薫; 米阪仁雄; 林秀敏 , 肺癌(Web) , 65 , 6 , 2025
Awards & Honors
- 2023, 日本臨床腫瘍学会, 奨励賞
- 2022, 西日本がん研究機構, 有吉福岡賞
- 2011, 上原記念生命科学財団, 平成23年度ポストドクトラルフェローシップ
Research Grants & Projects
- Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Analysis of the risk factors for the development and severity of immune-related adverse events by immune checkpoint inhibitors , Kindai University